GL1X · GenesisL1 explorer

Research workbench

Mineralocorticoid receptor ligand-binding domain with non-steroidal antagonist

Analyse Mineralocorticoid receptor ligand-binding domain with non-steroidal antagonist in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
3VHV
Type
protein
Length
255 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Mineralocorticoid receptor
UniProt
P08235
Ligands
LD1, LD2, K
Pockets
3 · best druggability 0.84

Structure

x-ray diffraction · 1 distinct chain · 68% helix, 5% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AMineralocorticoid receptorprotein25568% helix, 5% strandP08235

Ligands and binding sites

  • LD1 · 6-[(7S)-7-phenyl-7H-[1,2,4]triazolo[3,4-b][1,3,4]thiadiazin-6-yl]-2H-1,4-benzoxazin-3(4H)-one · ligand · chains A
  • LD2 · 6-[(1E)-2-phenyl-N-(3-sulfanyl-4H-1,2,4-triazol-4-yl)ethanimidoyl]-2H-1,4-benzoxazin-3(4H)-one · ligand · chains A
  • K · Potassium ion · metal · chains A
  • EDO · 1,2-ethanediol · additive · 2 copies · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

3 pockets found on a 1 Å grid, 2 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
11770.840.9828LD1
21720.670.8624empty
3770.460.8215empty

Compared structures

  • 3VHV · Mineralocorticoid receptor ligand-binding domain with non-steroidal antagonist · the same entry in another collection · chain A against A, TM-score 1.00
  • P08235 · AlphaFold monomer V2.0 prediction for mineralocorticoid receptor (P08235) · a predicted model of the same protein · chain A against A, TM-score 0.96

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.